Healthcare AI Acquisition Corp.
HAIAW · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | 1.96 | -0.01 | 20.97 |
| FCF Yield | 0.00% | 0.00% | -0.18% | -0.48% |
| EV / EBITDA | 0.00 | -902.53 | -696.49 | -166.19 |
| Quality | ||||
| ROIC | 0.00% | -1.64% | -2.21% | -6.22% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.32 | 42.23 | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 62.06% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -16.82 | -11.29 | -2.38 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |